valine has been researched along with Myocardial Ischemia in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Burgess, S; Fan, B; Zhao, JV | 1 |
| Amiya, E; Hirata, Y; Hosoya, Y; Kawarasaki, S; Nagai, R; Nakao, T; Omori, K; Ozeki, A; Tahara, Y; Takata, M; Watanabe, A; Watanabe, M; Watanabe, S; Yamada, N | 1 |
| Dahlöf, B; Kanae, K; Mochizuki, S; Shimizu, M; Tajima, N; Taniguchi, I; Yoshida, S | 1 |
| Duarte, AI; Gonçalves, LM; Monteiro, P; Providência, LA | 1 |
| Ito, S; Kageyama, N; Nakaya, Y; Nomura, M; Watanabe, T | 1 |
| Burneckiene, J; Rodovicius, H | 1 |
| Holm, J; Norlund, L; Ohlin, AK; Zöller, B | 1 |
| Fujimura, Y; Hayashi, N; Kometani, M; Nakao, K; Yamamoto, S | 1 |
| Hayashi, N; Kometani, M; Nakao, K; Yamamoto, S | 1 |
2 trial(s) available for valine and Myocardial Ischemia
| Article | Year |
|---|---|
Effect of add-on aliskiren to type 1 angiotensin receptor blocker therapy on endothelial function and autonomic nervous system in hypertensive patients with ischemic heart disease.
Topics: Aged; Amides; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Autonomic Nervous System; Comorbidity; Drug Therapy, Combination; Endothelium, Vascular; Female; Fumarates; Heart Rate; Humans; Hypertension; Male; Middle Aged; Myocardial Ischemia; Renin; Tetrazoles; Treatment Outcome; Valine; Valsartan; Vasodilation | 2014 |
JIKEI HEART Study--a morbi-mortality and remodeling study with valsartan in Japanese patients with hypertension and cardiovascular disease.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Antihypertensive Agents; Cardiovascular Diseases; Female; Follow-Up Studies; Heart Failure; Humans; Hypertension; Japan; Male; Middle Aged; Myocardial Ischemia; Quality of Life; Tetrazoles; Treatment Outcome; Valine; Valsartan; Ventricular Function, Left; Ventricular Remodeling | 2004 |
7 other study(ies) available for valine and Myocardial Ischemia
| Article | Year |
|---|---|
Using genetics to examine the overall and sex-specific associations of branch-chain amino acids and the valine metabolite, 3-hydroxyisobutyrate, with ischemic heart disease and diabetes: A two-sample Mendelian randomization study.
Topics: Amino Acids; Diabetes Mellitus; Female; Humans; Hydroxybutyrates; Male; Mendelian Randomization Analysis; Myocardial Ischemia; Valine | 2023 |
Valsartan improves mitochondrial function in hearts submitted to acute ischemia.
Topics: Acute Disease; Adenosine Diphosphate; Adenosine Triphosphate; Angiotensin II Type 1 Receptor Blockers; Animals; Heart; In Vitro Techniques; Intracellular Membranes; Membrane Potentials; Mitochondria, Heart; Myocardial Ischemia; Oxidative Phosphorylation; Oxygen Consumption; Rats; Rats, Wistar; Tetrazoles; Time Factors; Valine; Valsartan | 2005 |
Relationship between adhesion molecules with hs-CRP and changes therein after ARB (Valsartan) administration in patients with obstructive sleep apnea syndrome.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Arteriosclerosis; C-Reactive Protein; Case-Control Studies; Female; Humans; Intercellular Adhesion Molecule-1; Interleukin-6; Male; Middle Aged; Myocardial Ischemia; Sleep Apnea, Obstructive; Tetrazoles; Valine; Valsartan | 2006 |
Seasonal differences in activities of rabbit liver tRNA and aminoacyl-tRNA synthetases specific for valine and arginine under myocardial ischemia.
Topics: Acute Disease; Amino Acyl-tRNA Synthetases; Animals; Arginine; Disease Models, Animal; Liver; Male; Myocardial Ischemia; Protein Biosynthesis; Rabbits; RNA, Transfer; Seasons; Time Factors; Valine | 2006 |
A common thrombomodulin amino acid dimorphism is associated with myocardial infarction.
Topics: Adult; Age of Onset; Alanine; Alleles; Codon; Disease Susceptibility; DNA Mutational Analysis; Female; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Point Mutation; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Single-Stranded Conformational; Protein C; Thrombomodulin; Valine | 1997 |
Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 4th communication: improvement of heart failure of rats with myocardial infarction by valasartan.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Cardiomegaly; Enalapril; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Organ Size; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles; Valine; Valsartan; Vascular Resistance; Ventricular Function, Left | 1997 |
Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 5th communication: hemodynamic effects of valsartan in dog heart failure models.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Cardiac Output; Coronary Vessels; Dogs; Enalaprilat; Female; Heart Rate; Hemodynamics; Male; Myocardial Ischemia; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Stroke Volume; Tetrazoles; Valine; Valsartan; Vascular Resistance; Ventricular Function, Left | 1997 |